TITUR Platform Unlocks Safer mRNA Cancer Immunotherapy
Researchers have developed a modular mRNA platform that overcomes critical safety limitations in cancer immunotherapy. The TITUR system combines tumor-targeting nanoparticles with microRNA regulation for precise tumor killing.